[{"id":"3bb45c0b-82f2-4050-8899-8d4a9efd15c0","acronym":"","url":"https://clinicaltrials.gov/study/NCT02993159","created_at":"2021-01-18T14:43:26.101Z","updated_at":"2024-07-02T16:36:37.043Z","phase":"Phase 2b","brief_title":"Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast","source_id_and_acronym":"NCT02993159","lead_sponsor":"Northwestern University","biomarkers":" ER • IGF1 • CD68","pipe":" | ","alterations":" ER positive","tags":["ER • IGF1 • CD68"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e afimoxifene • Soltamox (tamoxifen citrate)"],"overall_status":"Recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 05/31/2017","start_date":" 05/31/2017","primary_txt":" Primary completion: 07/15/2022","primary_completion_date":" 07/15/2022","study_txt":" Completion: 07/15/2023","study_completion_date":" 07/15/2023","last_update_posted":"2020-12-21"}]